US FDA has issued Establishment Inspection Report (EIR) for Granules Pharmaceuticals, Inc. facility, a wholly-owned foreign subsidiary of the Company located in Chantilly, Virginia, USA.
This facility was inspected by US FDA in August 2019 and there were two (2) minor observations during the inspection. The company has responded to the observations within the stipulated timeframe.
Shares of GRANULES INDIA LTD. was last trading in BSE at Rs.129.15 as compared to the previous close of Rs. 128.65. The total number of shares traded during the day was 282050 in over 4372 trades.
The stock hit an intraday high of Rs. 135.85 and intraday low of 128.25. The net turnover during the day was Rs. 37096802.